Möchten Sie immer auf dem neuesten Stand bleiben?

Ottawa, April 28, 2026 (GLOBE NEWSWIRE) -- The global North America packaging market size stood at USD 333.86 billion in 2025 and is projected to reach USD 510.10 billion by 2035, according to a...

Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led Clinical Study in Pachyonychia...

– ARCALYST® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth –– ARCALYST 2026 expected net product revenue increased to $930 - $945 million –– KPL-387...

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Targeted Drug Delivery Market - Forecast from 2026 to 2031" report has been added to ResearchAndMarkets.com's offering.The Targeted Drug Delivery...

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Controlled Release Drug Delivery Market - Forecast from 2026 to 2031" report has been added to ResearchAndMarkets.com's offering.The Controlled...

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Microneedles for Vaccination Market - Forecast from 2026 to 2031" report has been added to ResearchAndMarkets.com's offering.The Microneedles For...

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Dermal Mycosis Market - A Global and Regional Analysis: Focus on Drug Type and Region, 2025-2035" report has been added to ResearchAndMarkets.com's...

PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European Union Approval based on strength of data from two pivotal Phase 3 studies studying PALSONIFY in both...

Addition Therapeutics announces multiple oral and poster presentations at the upcoming ASGCT Annual Meeting, May 11-15, 2026, in Boston.

New York, USA, April 27, 2026 (GLOBE NEWSWIRE) -- Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment...